On this page
The shingles vaccine in the U.S. is Shingrix, given as two doses a few months apart. The CDC recommends it for adults 50 and older, and for adults 19 and older with weakened immune systems. It is more than 90% effective at preventing shingles — but it does not treat an active case.
Almost everyone who has had chickenpox carries the virus that causes shingles, quietly dormant in the nerve roots for decades. The shingles vaccine is the one thing that meaningfully changes those odds — and it works remarkably well. If you're old enough to be eligible, it's among the highest-value vaccines available to adults.
This guide covers the vaccine used today, who the CDC recommends it for and at what age, how protective it actually is, and what the shot itself feels like. It's prevention, not treatment: if you already have a rash, scroll down for what to do instead.
What the shingles vaccine is
The shingles vaccine used in the United States is Shingrix — its generic name is recombinant zoster vaccine, often shortened to RZV. "Recombinant" simply means it's built from a piece of the virus rather than a weakened live version, so it can be given to people whose immune systems aren't able to handle a live vaccine.
Shingrix is given as two doses, spaced a few months apart — commonly two to six months between the first shot and the second. Both doses matter: a single dose offers only partial protection, and finishing the series is what delivers the high, durable effectiveness the vaccine is known for.
Shingrix replaced an older shingles vaccine called Zostavax, which used a weakened live virus. Zostavax is no longer used or available in the U.S. If you received it years ago, that doesn't mean you're covered today — the newer vaccine is both more effective and more durable, which is why it's recommended even for people who already got the older one.
If you do one thing to lower your odds of ever getting shingles, make it the two-dose Shingrix series. Nothing else comes close, and it's a decision you only have to make once.
— John Venzor, DO
Who should get it, and when
The shingles vaccine isn't only for people who feel at risk — the recommendation is broad, because the lifetime odds of shingles are high for nearly everyone who has had chickenpox. The CDC's guidance covers the following groups:
- Adults aged 50 and older. This is the core recommendation. Two doses of Shingrix are advised for every healthy adult at 50 or above, regardless of whether they remember having chickenpox.
- Adults 19 and older with weakened immune systems. People who are immunocompromised — from disease, medication, or treatment — face a higher risk of shingles and its complications, so the recommendation starts earlier for them, at age 19.
- People who have already had shingles. A past episode doesn't make you immune; shingles can return. Vaccination is still recommended to lower the chance of another bout.
- People who got the older Zostavax vaccine. Shingrix is recommended even if you were vaccinated with Zostavax in the past, because it offers stronger, longer-lasting protection.
- People who aren't sure they ever had chickenpox. The vast majority of adults were exposed, often without a clear memory of it, so there's no need to test for it first — the recommendation stands regardless.
Because Shingrix is given at pharmacies and clinics rather than online, this is one area where the next step is an in-person visit. Most pharmacies stock it and can administer both doses; a quick call to confirm availability and to ask about cost or coverage is usually all it takes to get scheduled.
How well it works
Shingrix is one of the most effective vaccines available to adults. In healthy adults, it is more than 90% effective at preventing shingles — a level of protection that holds up across age groups, including older adults, where many vaccines tend to weaken. For a common, painful condition, that's an exceptional result.
Just as importantly, the vaccine lowers the risk of the complication people fear most: lingering nerve pain. By preventing most cases of shingles outright — and blunting the ones that do occur — Shingrix substantially reduces the odds of postherpetic neuralgia, the burning nerve pain that can persist for months after the rash heals. Protection also stays strong for years after the second dose, rather than fading quickly.
No vaccine is perfect, and a small number of vaccinated people will still develop shingles. But when that happens after vaccination, the episode tends to be milder and less likely to leave nerve pain behind. The math strongly favors getting both doses.
What to expect from the shot
Shingrix is known for producing a noticeable reaction in many people — and that's a feature, not a flaw. The vaccine is designed to provoke a strong immune response, and the short-lived symptoms that follow are a sign that response is underway. Common, temporary side effects include:
- A sore arm at the injection site, sometimes with redness or swelling.
- Fatigue or a general run-down feeling for a day or two.
- Muscle aches, headache, or shivering.
- A low fever or upset stomach in some people.
These effects typically last only a day or two and resolve on their own. They can feel more pronounced after the second dose for some people — which is worth knowing in advance, because it's the most common reason someone is tempted to skip it. Don't. A reaction to the first shot is not a reason to abandon the series; both doses are needed for full, lasting protection, and the brief discomfort is a small price for years of coverage. It can help to schedule the shot when you have a quiet day afterward.
Prevention, not a cure
It's worth being clear about what the vaccine does and doesn't do. Shingrix is the single best way to prevent shingles — but it does nothing for a case that's already underway. If a rash has appeared, the vaccine can't shorten it, ease the pain, or lower the nerve-pain risk; only early antiviral treatment does that, and it works best when started within about 72 hours of the rash.
So think of the two as separate tools for separate moments. If you're healthy and shingles-free, the vaccine is your move — talk to a pharmacy and get the series started. If you're in the middle of an outbreak right now, the priority is fast antiviral treatment, and the vaccine is a conversation for after you've fully healed.